Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Essential Utilities
WTRG
$11.5B
| $6.76M | ﹤0.01% |
147,831
+125,497
| +562% | +$5.89M |
|
1002
State Street Materials Select Sector SPDR ETF
XLB
$8.82B
| $6.75M | ﹤0.01% |
164,006
+34,480
| +27% | +$1.45M |
|
1003
Kimco Realty
KIM
$17.7B
| $6.64M | ﹤0.01% |
318,578
+136,498
| +75% | +$2.83M |
|
1004
NovoCure
NVCR
$1.89B
| $6.6M | ﹤0.01% |
29,742
-19,519
| -40% | -$3.8M |
|
1005
Tractor Supply
TSCO
$16.5B
| $6.59M | ﹤0.01% |
176,975
-116,715
| -40% | -$4.28M |
|
1006
Toro Company
TTC
$9.08B
| $6.53M | ﹤0.01% |
59,443
-7,988
| -12% | -$878K |
|
1007
Charles River Laboratories
CRL
$11.6B
| $6.51M | ﹤0.01% |
+17,614
| New | +$5.88M |
|
1008
Arrow Electronics
ARW
$10.8B
| $6.44M | ﹤0.01% |
56,598
+41,519
| +275% | +$4.86M |
|
|
WWE
1009
DELISTED
World Wrestling Entertainment
WWE
| $6.44M | ﹤0.01% |
111,259
+44,615
| +67% | +$2.54M |
|
1010
Molina Healthcare
MOH
$10.5B
| $6.43M | ﹤0.01% |
25,429
+19,208
| +309% | +$4.83M |
|
|
DMRA
1011
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.81B
| $6.41M | ﹤0.01% |
51,980
-897
| -2% | -$122K |
|
1012
MarketAxess Holdings
MKTX
$4.34B
| $6.39M | ﹤0.01% |
13,784
-44,867
| -76% | -$21.4M |
|
1013
Amcor
AMCR
$21.6B
| $6.35M | ﹤0.01% |
110,820
-107,751
| -49% | -$6.41M |
|
1014
Acuity Brands
AYI
$10.3B
| $6.31M | ﹤0.01% |
+33,730
| New | +$6.13M |
|
|
SWI
1015
DELISTED
SolarWinds Corporation Common Stock
SWI
| $6.24M | ﹤0.01% |
+350,082
| New | +$6.33M |
|
1016
Occidental Petroleum
OXY
$53.6B
| $6.22M | ﹤0.01% |
198,993
-193,106
| -49% | -$5.18M |
|
1017
Chemours
CC
$2.57B
| $6.11M | ﹤0.01% |
175,549
+90,411
| +106% | +$2.99M |
|
1018
Bentley Systems
BSY
$10.9B
| $6.11M | ﹤0.01% |
94,240
-71,072
| -43% | -$3.91M |
|
|
FSTX
1019
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $6.1M | ﹤0.01% |
+714,285
| New | +$6.09M |
|
|
HES
1020
DELISTED
Hess
HES
| $6.08M | ﹤0.01% |
69,593
-7,115
| -9% | -$574K |
|
1021
Northrop Grumman
NOC
$78B
| $6.04M | ﹤0.01% |
16,621
-8,510
| -34% | -$3.06M |
|
|
BLU
1022
DELISTED
BELLUS Health Inc.
BLU
| $6.03M | ﹤0.01% |
1,943,389
-124,800
| -6% | -$477K |
|
|
PPL
1023
PPL Corp
PPL
$27.3B
| $6.02M | ﹤0.01% |
215,392
-11,575
| -5% | -$334K |
|
1024
Diamondback Energy
FANG
$53.5B
| $6M | ﹤0.01% |
63,871
+32,715
| +105% | +$2.7M |
|
1025
EyePoint Inc
EYPT
$1B
| $5.98M | ﹤0.01% |
664,498
-8,887
| -1% | -$85.3K |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.